A phase II randomized study of GM-CSF gene-modified autologous tumor vaccine (CG8123) with and without low-dose cyclophosphamide in advanced stage non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2007
At a glance
- Drugs Cyclophosphamide; Tumour cell vaccine-GVAX
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 22 Dec 2007 Status changed from in progress to completed.
- 08 Nov 2005 New trial record.